Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
| Parent link: | Molecules.— .— Basel: MDPI AG Vol. 30, iss. 11.— 2025.— Article number 2353, 26 p. |
|---|---|
| Other Authors: | Plotnikov M. B., Anishchenko A. M., Khlebnikov A. I. Andrey Ivanovich, Schepetkin I. A. Igor |
| Summary: | Title screen Disruption of the blood–brain barrier (BBB) accompanies many brain diseases, including stroke, neurodegenerative diseases, and brain tumors, leading to swelling, increased neuroinflammation, and neuronal death. In recent years, it has become clear that the c-Jun N-terminal kinase (JNK) signaling pathway is involved in disruption of the structural integrity of the BBB. Activation of the JNK signaling pathway has a negative effect on the functioning of the cellular elements of the neurovascular unit that form the BBB. The aim of this review is to assess the role of the JNK signaling pathway in the disruption of the structural integrity of the BBB in animal models of stroke (MCAO/R, middle cerebral artery occlusion with reperfusion), Alzheimer’s disease, and brain tumors and to analyze the effects of compounds of various natures that directly or indirectly affect the activity of the JNK signaling pathway. These compounds can reduce damage to the BBB and brain edema, reduce neuroinflammation and oxidative stress, reduce the expression of proapoptotic factors, and increase the expression of tight junction proteins. Certain compounds mitigate BBB dysfunction, being promising candidates for neuroprotective therapies. These agents exert their effects, in part, through inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway, a mechanism linked to reduced neuronal damage and improved BBB integrity Текстовый файл |
| Language: | English |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.3390/molecules30112353 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682272 |
Similar Items
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Published: (2019)
Published: (2019)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Published: (2018)
Published: (2018)
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Published: (2025)
Published: (2025)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Published: (2019)
Published: (2019)
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Published: (2020)
Published: (2020)
Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Published: (2019)
Published: (2019)
The IQ-1S JNK (c-Jun N-Terminal Kinase) Inhibitor Suppresses Premature Aging of OXYS Rat Brain; Neurochemical Journal; Vol. 17, iss. 3
Published: (2023)
Published: (2023)
Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S); Cells; Vol. 14, iss. 12
Published: (2025)
Published: (2025)
Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Published: (2024)
Published: (2024)
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Published: (2024)
Published: (2024)
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Published: (2025)
Published: (2025)
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Published: (2020)
Published: (2020)
Research on neural network analysis of MRI images of the brain for the diagnosis of brain diseases; Молодежь и современные информационные технологии
by: Tekere R. Richard
Published: (2025)
by: Tekere R. Richard
Published: (2025)
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Published: (2023)
Published: (2023)
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Published: (2023)
Published: (2023)
Оксим инденохиноксалинона IQ-1 как перспективный агент для разработки лекарственных препаратов; Перспективы развития фундаментальных наук; Т. 2 : Химия
by: Коврижина А. Р. Анастасия Руслановна
Published: (2024)
by: Коврижина А. Р. Анастасия Руслановна
Published: (2024)
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Published: (2023)
Published: (2023)
A review of Brain-Computer Interface technology; Control and Communications (SIBCON)
by: Stankevich Ph. V. Philippe Vladimirovich
Published: (2015)
by: Stankevich Ph. V. Philippe Vladimirovich
Published: (2015)
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Published: (2020)
Published: (2020)
Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats; Bulletin of Experimental Biology and Medicine; Vol. 175, iss. 6
Published: (2023)
Published: (2023)
Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127
Published: (2020)
Published: (2020)
The Effect of Tryptanthrin and Its Oxime on the Blood–Brain Barrier Permeability in Rats with Cerebral Infarction; Bulletin of Experimental Biology and Medicine; Vol. 179, iss. 2
Published: (2025)
Published: (2025)
Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Published: (2021)
Published: (2021)
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Published: (2023)
Published: (2023)
Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines; Molecules; Vol. 29, iss. 11
Published: (2024)
Published: (2024)
Brain Tractography in Diabetes Mellitus and Cognitive Impairments; Neuroscience and Behavioral Physiology; Vol. 51, No. 6
Published: (2021)
Published: (2021)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Published: (2018)
Published: (2018)
Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia; Frontiers in Chemistry; Vol. 9
Published: (2021)
Published: (2021)
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Published: (2022)
Published: (2022)
Interhemispheric asymmetry of the brain in patients with type 1 diabetes mellitus and cognitive impairment; Frontiers in Endocrinology; Vol. 13
Published: (2022)
Published: (2022)
Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Published: (2023)
Published: (2023)
Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats; Hypertension Research; Vol. 43
Published: (2020)
Published: (2020)
An Efficient Hybrid Fuzzy-Clustering Driven 3D-Modeling of Magnetic Resonance Imagery for Enhanced Brain Tumor Diagnosis; Electronics; Vol. 9, iss. 3
Published: (2020)
Published: (2020)
Segmentation of brain MRI using an altruistic Harris Hawks’ Optimization algorithm; Knowledge-Based Systems; Vol. 232
Published: (2021)
Published: (2021)
A wireless magnetoelectric-driven strategy to boost nose-to-brain drug delivery with сore-shell nanotransducers; Journal of Controlled Release; Vol. 389
Published: (2026)
Published: (2026)
Effect of Chronic Continuous Normobaric Hypoxia on Functional State of Cardiac Mitochondria and Tolerance of Isolated Rat Heart to Ischemia and Reperfusion: Role of µ and delta2 Opioid Receptors; Physiological Research; Vol. 68, iss. 6
Published: (2019)
Published: (2019)
Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 177, iss. 3
Published: (2024)
Published: (2024)
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Published: (2022)
Published: (2022)
Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial; The Journal of Thoracic and Cardiovascular Surgery; Vol. ХХХ
Published: (2018)
Published: (2018)
Tailoring the structure and phase composition of magnetoelectric nanotransducers for efficient neuromodulation under low-intensity magnetic fields; Ceramics International; Vol. 52, iss. 13, pt. A
Published: (2026)
Published: (2026)
Similar Items
-
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Published: (2019) -
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Published: (2018) -
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Published: (2025) -
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Published: (2019) -
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Published: (2020)